This newsletter provides a brief overview of the mandatory standards of producing Gx1 and Gx2 drugs, and Vietnam’s tender regulations governing these packages, with a short discussion on the impact of the European Union Vietnam Free Trade Agreement (“EU-VN FTA”) on Vietnam’s pharmaceutical market.
The newsletter is divided into three main sections, including:
- Drug classification,
- Tender Regulations Applicable to Gx1 and Gx2, and
- Impact of EU-VN FTA on Drug Procurement.